Opyl Ltd. (AU:OPL) has released an update.
Opyl Ltd. has made significant strides in Q3 FY24 with its TrialKey.ai platform, seeing a major expansion of its trial database and introducing AI-driven enhancements that boost clinical trial efficiency. The company has also divested its Opin business, improving cash flow and allowing for a sharper focus on TrialKey.ai’s growth and market presence. Leadership changes include the appointment of Saurabh Jain as Executive Chair, who will steer the company towards further commercialization of its flagship AI platform.
For further insights into AU:OPL stock, check out TipRanks’ Stock Analysis page.
